Stay updated with breaking news from Prosight Management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Finepoint Capital LP grew its position in shares of Galapagos NV (NASDAQ:GLPG – Get Rating) by 2.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 390,359 shares of the biotechnology company’s stock after acquiring an additional 10,657 shares during the […]
Finepoint Capital LP grew its position in shares of Galapagos NV (NASDAQ:GLPG – Get Rating) by 2.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 390,359 shares of the biotechnology company’s stock after acquiring an additional 10,657 shares during the […]
Investment analysts at StockNews.com assumed coverage on shares of Galapagos (NASDAQ:GLPG – Get Rating) in a report released on Thursday. The firm set a “hold” rating on the biotechnology company’s stock. GLPG has been the topic of a number of other reports. Morgan Stanley cut their target price on Galapagos from $44.00 to $42.00 in […]
Longboard Pharmaceuticals (NASDAQ:LBPH – Get Rating) had its price target raised by Cantor Fitzgerald from $11.00 to $16.00 in a research report report published on Thursday, The Fly reports. Other research analysts have also issued reports about the company. Citigroup dropped their price target on Longboard Pharmaceuticals from $24.00 to $17.00 and set a buy […]
Longboard Pharmaceuticals (NASDAQ:LBPH – Get Rating) had its price target increased by Cantor Fitzgerald from $11.00 to $16.00 in a report published on Thursday, The Fly reports. A number of other research firms have also weighed in on LBPH. HC Wainwright reiterated a buy rating and issued a $25.00 price objective on shares of Longboard […]